Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Transl Stroke Res. 2019 May 2;11(1):147–160. doi: 10.1007/s12975-019-00707-w

Figure 7.

Figure 7.

Hypothetical model for the effects of OTC-induced neuroprotection in mouse brains after MCAO. OTC plays dual roles after I/R, by increase of GSH level and by upregulation of Ubqlnl protein level. This leads to alleviated oxidative stress and improved proteostasis, resulting in neuroprotection.